Effects of Hip Strengthening Training in Volleyball Players

October 24, 2024 updated by: Furkan Karaağaç, Dokuz Eylul University

The Effect of Hip Strength Training on Upper Extremity Function and Performance in Volleyball Players

In order to examine the effects of hip strength training on upper extremity function and performance, 60 healthy volleyball players with an age range of 13 to 40 years will be included in our study. Shoulder joint range of motion, shoulder and hip muscle strength, upper extremity functional performance, and spike speed will be evaluated. Participants will be randomly divided into 2 groups as Training Group (TG) (will receive 6-week, 3 days a week, hip strength training in addition to their sport-specific training) and Control Group (CG) (will continue their sport-specific training).

Evaluations will be repeated 3 times before exercise training, after 6 weeks of exercise training, and at the 12th week, and the results will be analyzed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

60 volleyball players will be included in our study. Assessments: 1. In the evaluation of upper extremity function and performance; strength of the shoulder internal and external rotator muscles will be measured with a hand-held dynamometer, shoulder internal and external rotation joint range of motion with a digital inclinometer, finally functional performance with closed kinetic chain upper extremity stability test and spike speed with a speed gun. 2. strength evaluation of the hip abductor, extensor, and external rotator muscles with a hand-held dynamometer. Participants will be randomly divided into 2 groups of 30 participants. The Training Group (TG) will receive 6 weeks of hip abduction, extension, and external rotation strengthening training in addition to their sport-specific training. Strengthening exercises will be done 3 days a week and every other day with a physiotherapist. Control Group (CG); will continue their sport-specific training. Evaluations will be repeated 3 times (before exercise training, after 6 weeks of exercise training, and at the end of the 12th week) and the results will be analyzed.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İzmir, Turkey
        • Dokuz Eylul University Department of Physiotherapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being between the ages of 13-40
  • Volunteer to participate,
  • To be training at least 2-3 session a week,
  • Having played volleyball for at least 3 years, actively participating in training and competitions,
  • To be able to complete all the evaluations to be made in the study

Exclusion Criteria:

  • Having a systemic musculoskeletal disease,
  • The occurrence of pain during the evaluations,
  • History of fracture, instability or surgery in the last 6 months,
  • Having an upper, lower extremity or spine injury (acute and/or active) in the last 6 months,
  • Being away from sports for the last 6 months due to pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training group
Hip strengthening exercises will be performed in the training group.
Hip strengthening exercises will be performed 3 times a week for 6 weeks in the training group. 3 exercises consisting of 2 sets and 10 repetitions will be performed every week. A rest interval will be given between sets.
No Intervention: Control group
The control group will continue their training and matches.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder strength
Time Frame: Baseline, 6 weeks later and 12 weeks later
Change of shoulder internal rotation and external rotation strength(in kg, with hand held dynamometer)
Baseline, 6 weeks later and 12 weeks later
Upper extremity functional performance
Time Frame: Baseline, 6 weeks later and 12 weeks later
Determine the performance with Upper Extremity Closed Kinetic Chain Stabilization Test (number of touches)
Baseline, 6 weeks later and 12 weeks later
Spike speed
Time Frame: Baseline, 6 weeks later and 12 weeks later
Determine the performance with Spike Speed Test(in km/h, with radar gun)
Baseline, 6 weeks later and 12 weeks later

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder range of motion
Time Frame: Baseline, 6 weeks later and 12 weeks later
Change of shoulder internal and external rotation range of motion(in degree, with inclinometer)
Baseline, 6 weeks later and 12 weeks later
Hip strength
Time Frame: Baseline, 6 weeks later and 12 weeks later
Change of hip abduction, extension, and external rotation strength(in kg, with hand held dynamometer)
Baseline, 6 weeks later and 12 weeks later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sevgi Sevi YESİLYAPRAK, PHD, PT, Dokuz Eylul University Department of Physiotherapy and Rehabilitation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 27, 2023

Primary Completion (Actual)

January 30, 2024

Study Completion (Actual)

January 30, 2024

Study Registration Dates

First Submitted

August 9, 2023

First Submitted That Met QC Criteria

August 9, 2023

First Posted (Actual)

August 18, 2023

Study Record Updates

Last Update Posted (Actual)

October 28, 2024

Last Update Submitted That Met QC Criteria

October 24, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 7584-GOA

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Training group

Subscribe